Cepi funds three prospective vaccines targeting the epidemic-causing Ebola virus
Portfolio includes candidates under development by IAVI, Moderna and University of Oxford manufactured at Serum Institute of India.
Search fresh public links, source activity, and ready-to-use post angles for Cepi Chief Executive Officer.
Fresh curated links around CEPI Chief Executive Officer are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Portfolio includes candidates under development by IAVI, Moderna and University of Oxford manufactured at Serum Institute of India.
It noted that the Bundibugyo outbreak had resulted in more than 560 confirmed infections and over 100 confirmed deaths. The post CEPI invests $1.9m to accelerate Ebola Vaccine deve...
The PIE sat down with Mervin Bakker, EAIE executive director, to talk about his carer journey, building a professional network and his organisation's upcoming conference. The post...
Adar Poonawalla is the Chief Executive Officer (CEO) of the Serum Institute of India (SII), the world's largest vaccine manufacturer by the number of doses produced. He is widely r...
Today, Pixee Medical announced the appointment of American healthcare executive Kristoff Goson as new Chief Executive Officer.
Kristoff Goson – Pixee Medical CAMBRIDGE, Mass., June 29, 2026 -(BUSINESS WIRE)-Today, Pixee Medical announced the appointment of…
Caroline Jupe - CEO Caroline Jupe is the CEO of the IMRF, a position she has held since February 2023. With over 16 years of experience in the UK charity sector, Caroline has wo...
Current head is stepping down after six years
Current head is stepping down after six years
APCO CEO Chris Foley is set to step down at the end of November 2026 after four years at the helm of the nonprofit body. The post APCO CEO to step down in November appeared first o...
The first vaccine against the Bundibugyo ebola virus is poised to enter phase 1 clinical trial.
Global health agencies launch manufacturer outreach backed by $40 million funding; Serum Institute-linked candidate among vaccines under evaluation
When Charles River Laboratories CEO Birgit Girshick started her career as an executive assistant with the company in Germany in 1989, she didn’t know what was possible for her care...
International SOS has announced the appointment of Chris Kibarian as Chief Executive Officer, Subscription Services. This newly created leadership role reflects the organisation’s...
The board has hired Russell Reynolds to lead the search for a successor
The recent Ebola and hantavirus outbreaks demonstrate that the world is still vulnerable to rapidly spreading infectious diseases, Tedros Ghebreyesus, the head of the World Health...
Christelle Huguet, Ph.D., Ipsen’s executive vice president and head of R&D, sits down with Fierce Healthcare & Life Sciences Editor-in-Chief Ayla Ellison to discuss pipelin...
René Kester has been appointed CEO of PB Group as of 1 June. He succeeds Richard Schmit, who retired early on 31 May. With his extensive international experience, Kester brings ope...
After 37 years of dedicated service to PDA and its members, Glenn E. Wright steps down as President & CEO effective June 30, 2026. Craig Elliott has been selected by the Board...
ACT-CHIK is an EU-funded project (roughly $17 million) led by Institut Pasteur that will advance chikungunya vaccine trials across four African countries and prepare local manufact...
Fiery, LLC, the California-based provider of digital front ends (DFEs) and workflow solutions for the global print industry, has named its Chief Financial and Operating Officer, Mi...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.